<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>VistaGen Therapeutics, Inc.</title><link>https://investorshangout.com/VistaGen-Therapeutics-Inc-VTGN-68376/</link><description><![CDATA[VistaGen Therapeutics, Inc. (VTGN)]]></description><language>en-us</language><pubDate>Mon, 26 Oct 2026 05:29:12 GMT</pubDate><copyright>Copyright InvestorsHangout.com</copyright><atom:link href="https://investorshangout.com/VistaGen-Therapeutics-Inc-VTGN-68376/" rel="self" type="application/rss+xml"/><item><title>whytestocks: $VTGN News Article - Anxiety-Focused Stock Vistagen Therapeutics Is An Undervalued Late-Stage Neurol</title><link>https://investorshangout.com/post/view?id=6643931</link><guid>https://investorshangout.com/post/view?id=6643931</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 14 Nov 2023 19:26:04 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - Vistagen To Report Second Quarter Financial Results and Host Corporate Update C</title><link>https://investorshangout.com/post/view?id=6641027</link><guid>https://investorshangout.com/post/view?id=6641027</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 06 Nov 2023 13:35:55 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - InvestorNewsBreaks - VistaGen Therapeutics Inc. (NASDAQ: VTGN), Fuji Pharma Co.</title><link>https://investorshangout.com/post/view?id=6615384</link><guid>https://investorshangout.com/post/view?id=6615384</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 05 Sep 2023 19:05:52 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - Vistagen and Fuji Enter Exclusive Negotiation Agreement for a Potential License</title><link>https://investorshangout.com/post/view?id=6615362</link><guid>https://investorshangout.com/post/view?id=6615362</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 05 Sep 2023 18:25:49 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - InvestorNewsBreaks - Vistagen Therapeutics Inc. (NASDAQ: VTGN) Schedules Releas</title><link>https://investorshangout.com/post/view?id=6606175</link><guid>https://investorshangout.com/post/view?id=6606175</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 09 Aug 2023 16:05:47 GMT</pubDate></item><item><title>znewcar1: VTGN Aft@13</title><link>https://investorshangout.com/post/view?id=6605427</link><guid>https://investorshangout.com/post/view?id=6605427</guid><description><![CDATA[znewcar1
]]></description><pubDate>Tue, 08 Aug 2023 02:43:30 GMT</pubDate></item><item><title>znewcar1: $VTGN Lod10.7 reach 19.25 S15?</title><link>https://investorshangout.com/post/view?id=6605265</link><guid>https://investorshangout.com/post/view?id=6605265</guid><description><![CDATA[znewcar1
]]></description><pubDate>Mon, 07 Aug 2023 17:05:55 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - VistaGen Therapeutics (VTGN Stock) Exploded 3,471% Here&#039;s Why </title><link>https://investorshangout.com/post/view?id=6605139</link><guid>https://investorshangout.com/post/view?id=6605139</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 07 Aug 2023 14:05:47 GMT</pubDate></item><item><title>znewcar1: News $VTGN PMH$60 August 7, 2023 8:30 AM Vistagen Announces Positive Top-Line Results from Phase 3</title><link>https://investorshangout.com/post/view?id=6605090</link><guid>https://investorshangout.com/post/view?id=6605090</guid><description><![CDATA[znewcar1
]]></description><pubDate>Mon, 07 Aug 2023 13:23:13 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - InvestorNewsBreaks - VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces New Pr</title><link>https://investorshangout.com/post/view?id=6597080</link><guid>https://investorshangout.com/post/view?id=6597080</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 17 Jul 2023 20:00:50 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - Vistagen Reports New Preclinical Data Supporting Itruvone (PH10) Nasal Spray&#039;s </title><link>https://investorshangout.com/post/view?id=6597074</link><guid>https://investorshangout.com/post/view?id=6597074</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 17 Jul 2023 19:55:47 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - InvestorNewsBreaks - Vistagen Therapeutics Inc. (NASDAQ: VTGN) Releases FY 2023</title><link>https://investorshangout.com/post/view?id=6591186</link><guid>https://investorshangout.com/post/view?id=6591186</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 29 Jun 2023 15:05:47 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - InvestorNewsBreaks - Vistagen Therapeutics Inc. (NASDAQ: VTGN) Scheduled Confer</title><link>https://investorshangout.com/post/view?id=6590650</link><guid>https://investorshangout.com/post/view?id=6590650</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 28 Jun 2023 14:40:47 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - Vistagen Announces Results of Successful U.S. Phase 1 Study of Itruvone (PH10),</title><link>https://investorshangout.com/post/view?id=6587885</link><guid>https://investorshangout.com/post/view?id=6587885</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 21 Jun 2023 12:55:48 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - Vistagen to Participate in the Maxim Group Healthcare Virtual Conference Hosted</title><link>https://investorshangout.com/post/view?id=6586578</link><guid>https://investorshangout.com/post/view?id=6586578</guid><description><![CDATA[whytestocks
]]></description><pubDate>Fri, 16 Jun 2023 12:45:46 GMT</pubDate></item><item><title>znewcar1: $VTGN 2623%RS1:30 v1M c2.71 f219,326M hod3.26 Guessing F is closer to 7.3M as it didn&#039;t change yet </title><link>https://investorshangout.com/post/view?id=6583272</link><guid>https://investorshangout.com/post/view?id=6583272</guid><description><![CDATA[znewcar1
]]></description><pubDate>Wed, 07 Jun 2023 22:22:37 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - InvestorNewsBreaks - Vistagen Therapeutics Inc. (NASDAQ: VTGN) Recognized with </title><link>https://investorshangout.com/post/view?id=6578560</link><guid>https://investorshangout.com/post/view?id=6578560</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 24 May 2023 17:55:46 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - InvestorNewsBreaks - VistaGen Therapeutics Inc. (NASDAQ: VTGN) Expands Portfoli</title><link>https://investorshangout.com/post/view?id=6557625</link><guid>https://investorshangout.com/post/view?id=6557625</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 06 Apr 2023 14:55:45 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - Vistagen Receives New European Patent for AV-101 </title><link>https://investorshangout.com/post/view?id=6557555</link><guid>https://investorshangout.com/post/view?id=6557555</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 06 Apr 2023 13:55:50 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - InvestorNewsBreaks - VistaGen Therapeutics Inc. (NASDAQ: VTGN) Receives Positiv</title><link>https://investorshangout.com/post/view?id=6554913</link><guid>https://investorshangout.com/post/view?id=6554913</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 30 Mar 2023 18:30:47 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - Vistagen Announces Positive Data in Fasedienol (PH94B) Phase 3 Open-Label Study</title><link>https://investorshangout.com/post/view?id=6551393</link><guid>https://investorshangout.com/post/view?id=6551393</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 22 Mar 2023 13:55:46 GMT</pubDate></item><item><title>znewcar1: $VTGN 27% v11,3M c.2289 f219,326M H.23 ML.14</title><link>https://investorshangout.com/post/view?id=6536340</link><guid>https://investorshangout.com/post/view?id=6536340</guid><description><![CDATA[znewcar1
]]></description><pubDate>Tue, 14 Feb 2023 04:31:24 GMT</pubDate></item><item><title>znewcar1: %VTGN 27% v31,0M c.1801 f219,326M H.2291 ML.1401=RL gap</title><link>https://investorshangout.com/post/view?id=6535494</link><guid>https://investorshangout.com/post/view?id=6535494</guid><description><![CDATA[znewcar1
]]></description><pubDate>Fri, 10 Feb 2023 22:33:24 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - InvestorNewsBreaks - VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Closin</title><link>https://investorshangout.com/post/view?id=6531050</link><guid>https://investorshangout.com/post/view?id=6531050</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 02 Feb 2023 16:25:51 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - InvestorNewsBreaks - VistaGen Therapeutics Inc. (NASDAQ: VTGN) Doses First Part</title><link>https://investorshangout.com/post/view?id=6526592</link><guid>https://investorshangout.com/post/view?id=6526592</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 24 Jan 2023 17:45:46 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - Vistagen Announces First Participants Dosed in Phase 1 Clinical Trial of PH10, </title><link>https://investorshangout.com/post/view?id=6526591</link><guid>https://investorshangout.com/post/view?id=6526591</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 24 Jan 2023 17:44:41 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - InvestorNewsBreaks - VistaGen Therapeutics Inc. (NASDAQ: VTGN) Completes 4-Week</title><link>https://investorshangout.com/post/view?id=6521018</link><guid>https://investorshangout.com/post/view?id=6521018</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 10 Jan 2023 17:05:51 GMT</pubDate></item><item><title>znewcar1: $VTGN 26% v15,6M c.13 f206,836M H.1388 ML.09</title><link>https://investorshangout.com/post/view?id=6518047</link><guid>https://investorshangout.com/post/view?id=6518047</guid><description><![CDATA[znewcar1
]]></description><pubDate>Tue, 03 Jan 2023 21:40:16 GMT</pubDate></item><item><title>znewcar1: $VTGN 30% v6,0M c.147 f206,8M H.147 lod.0981 H.1238</title><link>https://investorshangout.com/post/view?id=6511995</link><guid>https://investorshangout.com/post/view?id=6511995</guid><description><![CDATA[znewcar1
]]></description><pubDate>Fri, 16 Dec 2022 21:25:27 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - KCSA Mental Health Virtual Investor Conference Agenda Announced for December 15</title><link>https://investorshangout.com/post/view?id=6510423</link><guid>https://investorshangout.com/post/view?id=6510423</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 13 Dec 2022 15:35:51 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - InvestorNewsBreaks - VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces FDA Fa</title><link>https://investorshangout.com/post/view?id=6507513</link><guid>https://investorshangout.com/post/view?id=6507513</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 06 Dec 2022 17:35:46 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - Vistagen Receives FDA &quot;Study May Proceed&quot; Letter Under its Investigational New </title><link>https://investorshangout.com/post/view?id=6504779</link><guid>https://investorshangout.com/post/view?id=6504779</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 30 Nov 2022 15:05:51 GMT</pubDate></item><item><title>znewcar1: $VTGN 24% v8,3m c.162 f206,8M H.1634 ml.0768</title><link>https://investorshangout.com/post/view?id=6497311</link><guid>https://investorshangout.com/post/view?id=6497311</guid><description><![CDATA[znewcar1
]]></description><pubDate>Fri, 11 Nov 2022 22:49:06 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - InvestorNewsBreaks - VistaGen Therapeutics Inc. (NASDAQ: VTGN) Releases Q2 2023</title><link>https://investorshangout.com/post/view?id=6497030</link><guid>https://investorshangout.com/post/view?id=6497030</guid><description><![CDATA[whytestocks
]]></description><pubDate>Fri, 11 Nov 2022 15:15:52 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - InvestorNewsBreaks - VistaGen Therapeutics Inc. (NASDAQ: VTGN) to Host Virtual </title><link>https://investorshangout.com/post/view?id=6489935</link><guid>https://investorshangout.com/post/view?id=6489935</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 26 Oct 2022 20:30:54 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - Vistagen to Host Concordia Live Webinar on Mental Health with Leaders from McKi</title><link>https://investorshangout.com/post/view?id=6489715</link><guid>https://investorshangout.com/post/view?id=6489715</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 26 Oct 2022 15:01:06 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - InvestorNewsBreaks - VistaGen Therapeutics Inc. (NASDAQ: VTGN) CEO to Participa</title><link>https://investorshangout.com/post/view?id=6479847</link><guid>https://investorshangout.com/post/view?id=6479847</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 03 Oct 2022 19:21:05 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - Vistagen to Participate at Cantor Neurology &amp; Psychiatry Conference </title><link>https://investorshangout.com/post/view?id=6479842</link><guid>https://investorshangout.com/post/view?id=6479842</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 03 Oct 2022 19:15:55 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - Vistagen CEO Shawn Singh to Join Executive Roundtable Discussing Mental Health </title><link>https://investorshangout.com/post/view?id=6473216</link><guid>https://investorshangout.com/post/view?id=6473216</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 20 Sep 2022 12:45:54 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - InvestorNewsBreaks - VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Partic</title><link>https://investorshangout.com/post/view?id=6468168</link><guid>https://investorshangout.com/post/view?id=6468168</guid><description><![CDATA[whytestocks
]]></description><pubDate>Fri, 09 Sep 2022 16:05:53 GMT</pubDate></item><item><title>znewcar1: VTGN 18% v66,4M c.1953 f206,8M H.2374 ML.15 YL.16</title><link>https://investorshangout.com/post/view?id=6467787</link><guid>https://investorshangout.com/post/view?id=6467787</guid><description><![CDATA[znewcar1
]]></description><pubDate>Thu, 08 Sep 2022 22:08:03 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - InvestorNewsBreaks - VistaGen Therapeutics Inc. (NASDAQ: VTGN) to Report FY 202</title><link>https://investorshangout.com/post/view?id=6467399</link><guid>https://investorshangout.com/post/view?id=6467399</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 08 Sep 2022 15:00:49 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - Vistagen to Proceed with PALISADE-2 Phase 3 Clinical Trial of PH94B in Social A</title><link>https://investorshangout.com/post/view?id=6467382</link><guid>https://investorshangout.com/post/view?id=6467382</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 08 Sep 2022 14:45:49 GMT</pubDate></item><item><title>znewcar1: VTGN 23% v24,6M c.1931 f206,8MH.1986 ML.1388</title><link>https://investorshangout.com/post/view?id=6456796</link><guid>https://investorshangout.com/post/view?id=6456796</guid><description><![CDATA[znewcar1
]]></description><pubDate>Thu, 18 Aug 2022 00:29:00 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - Penny Stocks To Buy? 3 Under $0.99 For Your Watch List </title><link>https://investorshangout.com/post/view?id=6456702</link><guid>https://investorshangout.com/post/view?id=6456702</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 17 Aug 2022 19:45:52 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - VistaGen Therapeutics to Report Fiscal Year 2022 Financial Results on June 23, </title><link>https://investorshangout.com/post/view?id=6423546</link><guid>https://investorshangout.com/post/view?id=6423546</guid><description><![CDATA[whytestocks
]]></description><pubDate>Fri, 17 Jun 2022 14:40:53 GMT</pubDate></item><item><title>znewcar1: VTGN 24% v5,1M c1.73 f206,5M H1.79</title><link>https://investorshangout.com/post/view?id=6383252</link><guid>https://investorshangout.com/post/view?id=6383252</guid><description><![CDATA[znewcar1
]]></description><pubDate>Thu, 14 Apr 2022 02:40:32 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - InvestorNewsBreaks - VistaGen Therapeutics Inc. (NASDAQ: VTGN) Releases Plans Q</title><link>https://investorshangout.com/post/view?id=6214198</link><guid>https://investorshangout.com/post/view?id=6214198</guid><description><![CDATA[whytestocks
]]></description><pubDate>Fri, 13 Aug 2021 17:20:49 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - InvestorNewsBreaks - VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Partic</title><link>https://investorshangout.com/post/view?id=6203705</link><guid>https://investorshangout.com/post/view?id=6203705</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 02 Aug 2021 16:50:48 GMT</pubDate></item><item><title>whytestocks: $VTGN News Article - VistaGen Therapeutics to Participate in Canaccord Genuity 41st Annual Growth Co</title><link>https://investorshangout.com/post/view?id=6203702</link><guid>https://investorshangout.com/post/view?id=6203702</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 02 Aug 2021 16:45:48 GMT</pubDate></item></channel></rss>